Coenzyme Q10 Gummy
Natural health product licensed in Canada
- Other names
- CoQ10 Gummy
- Licence holder
- Canada Optimal Nature Inc.
- NPN or DIN-HM
- 80071881
- Status
- Active licence
- Licence date
- 10 August 2016
- Revision date
- 30 September 2020
- Form
- Bloc
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 100 milligramme | Not calculated |
Non-medicinal ingredients
Huile de noix de coco, pectine, Natural fruit Flavor, Extrait de Stevia, Tapioca syrup, jus de fruits, Jus de carotte noire, Eau purifiée, Bêta-carotène, Cire de Carnauba, Carrageen, citrate de sodium, Acide citrique anhydre
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Bloc(s) ; maximum: 3 Bloc(s) | 1 Tous les jours |
Uses authorised in Canada
Helps to maintain and/or support cardiovascular health. Helps to reduce the frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic. An antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking blood pressure medication. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner if migraine frequency increases, and associated nausea and vomiting persist or worsen.
Source
Official Health Canada record, licence 80071881
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging